- Tolerogenní dendritické buňky a jejich využití v léčbě imunopatologických stavů2017 | 2. lékařská fakulta
- Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?2019 | 2. lékařská fakulta
- NF-kappa B, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment2015 | 2. lékařská fakulta
- Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells2017 | 2. lékařská fakulta
- Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (toIDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice2018 | 2. lékařská fakulta
- Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?2019 | 2. lékařská fakulta